Evidence map›Paper›PMID 39805980›Full record

ArticleScientific reports2025

Reference intervals of inhibin B in Chinese children on chemiluminescence analyzer.

Bin Zhou, Jinjun Luo, Xiang Dai, Xuelian He, Hui Yao

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bin ZhouTongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital, Huazhong University of Science & Technology, Wuhan, 430000, China.
Jinjun LuoHubei Provincial Center for Disease Control and Prevention, Wuhan, 430000, China.
Xiang DaiTongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital, Huazhong University of Science & Technology, Wuhan, 430000, China.
Xuelian He *Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital, Huazhong University of Science & Technology, Wuhan, 430000, China. hexuelian2013@hotmail.com.
Hui Yao *Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital, Huazhong University of Science & Technology, Wuhan, 430000, China. huiyaomail@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibin B (INHB) is an emerging biomarker of sexual function diseases, but its clinical use in children is hindered due to the lacking reference intervals (RIs) based on age and sex. A total of 622 healthy Chinese children including 48.6% females and 51.4% males were included and serum INHB and six conventional sex hormones were measured. INHB was partitioned by four predetermined age groups (< 1 year, 1-5 years, 5-10 years, 10-18 years) and the corresponding RIs were determined with quantile. The effect of age on INHB was assessed using five models including linear, quadratic, cubic, S, and logarithmic. Spearman correlation was used to examine the associations between INHB and sex hormones. Compared to the boys, girls had lower median concentrations and variability in INHB across all four age groups. The optimal models for the effect of age on INHB were cubic (R

Indexed as

InhibinsLuminescent MeasurementsAdolescentAge FactorsBiomarkersChildChild, PreschoolChinaEast Asian PeopleFemaleHumansInfantMaleReference ValuesBiomarkersinhibin BInhibinsAgeChildrenInhibin BReference intervalsSexual function

Identifiers

PMID39805980
PMCPMC11730302

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.